Latest Breaking News On - Gilles weder - Page 1 : comparemela.com

CSEM and ClexBio Create a Bioreactor for Tissue-Engineered Cardiovascular Implants

A new type of bioreactor that can grow human veins in the lab has been developed by CSEM and ClexBio, a Nordics-based startup specialized in regenerative medicine.

Gilles wederMaria osipovaResearch council of norwayHead of researchResearch councilBiodegradable matrixCreate humanSenior project managerCell microtechnologiesLife science technologiesChronic venous

Democratizing RNA sequencing: A breakthrough in cost and efficiency

CSEM has supported the Lausanne-based start-up Alithea Genomics in developing a technology capable of processing hundreds of ribonucleic acid (RNA) samples in a single tube, which translates to a significant reduction in reagents and manual effort in the overall workflow.

Riccardo daineseGilles wederMaria osipovaHead research business development life science technologiesTools for life sciencesLaboratory of systems biologyAlithea genomicsSystems biologyLife sciencesMicrofluidic pooling lidSenior project managerSmart lidSwitzerland innovation park basel areaCo head researchBusiness development life science technologiesNa sequencing

Making Personalized Cancer Therapies Accessible to All

CSEM has supported Lausanne-based start-up Limula in its mission to make cell therapies more affordable, and to facilitate access to these personalized treatments.

Gilles wederYann pierson limulaMaria osipovaDiane ledroitLuc henry limulaYann piersonHead research business development life science technologiesVincent revolCo head researchBusiness development life science technologiesSenior engineer cell microtechnologiesLuc henryLimula kitImage creditGene therapySingle bioreactor

A silent killer, liver cancer prompts race to improve organ replacements

A silent killer, liver cancer prompts race to improve organ replacements
scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.

Gilles wederEuropean innovation councilHealth policyPortugal based ophiomics precision medicinePereira leal

Multi-axis Bioreactor: Preclinical Assessment of Intervertebral Disc Tissues

Advanced bioreactors enable investigators to maintain viable tissue samples in closed systems under laboratory conditions. A multi-axis bioreactor has been designed for therapy testing to address the unmet need for the long-term culture of intervertebral discs under complex mechanical stimulation.

Gilles wederDiane ledroitMauro aliniShangbin cuiZhen liSarah heubStephenj fergusonAstrid soubrierAapo ristaniemiTools for life sciencesAo research institute davosNeed mechanicalLife sciencesIntervertebral disc tissueInstitute davosBiomaterials science